Bold-200-2

Bold 200 (Equipoise – Boldenone Undecylenate)

$54.00

Manufacturer: Geneza Pharmaceuticals
Category: Injectable Steroids
Substance: Equipoise (Boldenone Undecylenate)
Package: 10 ml/vial (200 mg/ml)

Category: .

Product Description

GP Bold 200, by Geneza Pharmaceuticals, is an injectable steroid which contains the hormone Boldenone Undeclynate.

The preparation comes in vials of 10mls and contains 200mgs of Boldenone Undeclynate per ML.

Boldenone Undeclynate has become a very popular steroid with athletes and bodybuilders due to the fact that it has very low side effects and has anabolic properties which promote a steady gain in quality muscle mass over time. The steroid was tagged with the name EquiposeВ® when it first became available as a veterinary steroid and was widely used in racehorses.

EQ, as it is often called, can be effectively incorporated in both “cutting” and “bulking” cycles due to the well balanced effects of this anabolic substance. This steroid aromatizes very little, and therefore produces almost no estrogenic side effects such as water retention or “gyno” (the development of female tissue under the nipples in males resulting in unattractive and often painful lumps in this area), and therefore is a favorite among bodybuilders who are looking to make solid gains without the extra bloat, or are nearing contest.

This steroid also dramatically increases protein synthesis and red blood cell count meaning that nutrients are transported throughout the body much more effectively. Because of this, EquiposeВ® is able to make much more use of less food, enhancing its capabilities as an effective hormone to use when “cutting” and a bodybuilder is trying to reduce calories to get into contest shape. Also, the increased red blood cell count caused by this steroid also increases oxygen transportation throughout the body, thus giving athletes and bodybuilders much more endurance and the capability to endure cardio sessions for much longer periods of time, which obviously makes this drug even more popular among those looking to shed bodyfat.

Users of this anabolic also report a dramatic increase in vascularity, which can also be attributed to the oxidizing benefits of EQ. Bodybuilders using GP Bold 200 in a cutting cycle often look to stack it with an oral steroid such as Stanozolole or Oxandrolone to further increase anabolic activity while keeping estrogenic side effects out of the picture.

EQ also has properties which make it very favorable amongst Bodybuilders looking to incorporate it into their bulking cycles. Users of this steroid often report an increase in appetite and the ability to eat more food easily when trying to gain weight in the offseason. The mild nature and steady gains produced by GP Bold 200 also make it very effective for those looking to do longer cycles (12-20 weeks ), where as most users note a continuous gain in muscle mass and strength over this time and credit the steroid with helping the muscles maintain a more defined, vascular tone throughout bulking .

Bodybuilders looking for size often stack EQ with other anabolic drugs such as a testosterone preparation (GP Test Enanth 250, GP Test Cyp 250, GP Test Prop 100 etc.) and/or Deca-Durabolin . Bodybuilders looking to bulk might also incorporate an oral compound into this stack such as GP Oxan or GP Methan.

Women bodybuilders are also fond of this steroid due to its mild nature and low androgenic properties. The most often side effect of the drug being an increase in libido, women find that the drug rarely causes any masculizing side effects when kept in a reasonable dosage range.

Male bodybuilders generally take EQ in doses of 300-800mg’s a week for 8-20wks, depending on goals, while women bodybuilders often find a dosage of 50-100mg’s a week to be very effective for making quality gains while keeping side effects to a minimum. This steroid has a long half life (7-10) days and is most commonly injected twice per week to keep blood concentrations as steady as possible.

Equipoise® is the popularly referenced brand name for the veterinary injectable steroid boldenone undecylenate. Specifically it is a derivative of testosterone, which exhibits strong anabolic and moderately androgenic properties. The undecylenate ester greatly extends the activity of the drug (the undecylenate ester is only one carbon atom longer than decanoate), so that clinically injections would need to be repeated every three or four weeks. In veterinary medicine Equipoise© is most commonly used on horses, exhibiting a pronounced effect on lean bodyweight, appetite and general disposition of the animal. This compound is also said to shows a marked ability for increasing red blood cell production, although there should be no confusion that this is an effect characteristic of newly all anabolic/androgenic steroids. The favorable properties of this drug are greatly appreciated by athletes, Equipoise® being a very popular injectable in recent years. It is considered by many to be a stronger, slightly more androgenic Deca-Durabolin®. It is generally cheaper, and could replace Deca in most cycles without greatly changing the end result.

The side effects associated with Equipoise® are generally mild. The structure of boldenone does allow it to convert into estrogen, but it does not have an extremely high affinity to do so. To try and quantify this we can look toward aromatization studies, which suggest that its rate of estrogen conversion should be roughly half that of testosterone’s. The tendency to develop a noticeable amount of water retention with this drug would therefore be slightly higher than that with Deca-DurabolinO (with an estimated 20°/a conversion), but much less than what would be expected with a stronger agent such as Testosterone. While one does still have a chance of encountering an estrogen related side effect as such when using this substance, it is not a common problem when taken at a moderate dosage level. Gynecomastia might theoretically become a concern, but is usually only heaved of with very sensitive individuals or (again) those venturing high in dosage. Should estrogenic effects become troublesome, the addition of Nolvadex® and/or Proviron® should of course make the cycle more tolerable. An antiaromatase such as Cytadren® or Arimidex® would be stronger options, however probably not indicated with a mild drug as such.

Equipoise® can also produce distinct androgenic side effects. Incidences of oily skin, acne, increased aggression and hair loss are likewise all possible with this compound, although will typically be related to the use of higher doses. Women in fact find this drug quite comfortable, virilization symptoms usually unseen when taken at low doses. Boldenone does reduce to a more potent androgen (dihydroboldenone) via the 5alpha reductase enzyme (which produces DHT from testosterone), however its affinity for this interaction in the human body is low to nonexistent”. We therefore cannot consider the reductase inhibitor Proscar® to be of much use with Equipoise, as it would be blocking what is at best an insignificant path of metabolism for the steroid. And although this drug is relatively mild, it may still have a depressive effect on endogenous testosterone levels. A combination of HCG and Clomid®/Nolvadex® may likewise be needed at the conclusion of each cycle to avoid a “crash”, particularly when running long in duration.